机构:[1]Center for Medical Genetics, Hunan Key Laboratory of Medical Genetics, Key Lab of Rare Pediatric Diseases of Ministry of Education, School of Life Science, Central South University, Changsha, Hunan 410078, China.[2]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.神经科系统神经内科首都医科大学宣武医院[3]State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing 100101, China.[4]Center for Life Sciences, Institute of Molecular Medicine, School of Future Technology, Peking University, Beijing 100871, China.[5]Department of Basic Medical Sciences, Neuroscience Center, Shantou University Medical College, Shantou, Guangdong 515041, China.[6]Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Science, Central South University, Changsha, Hunan 410078, China.[7]Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
KCTD10, a member of the potassium channel tetramerization domain (KCTD) family, is implicated in neuropsychiatric disorders and functions as a substrate recognition component within the RING-type ubiquitin ligase complex. A rare de novo variant of KCTD10, p.C124W, was identified in schizophrenia cases, yet its underlying pathogenesis remains unexplored. Here, we demonstrate that heterozygous KCTD10 C124W mice display pronounced synaptic abnormalities and exhibit schizophrenia-like behaviors. Mechanistically, we reveal that KCTD10 undergoes liquid-liquid phase separation (LLPS), a process orchestrated by its intrinsically disordered region (IDR). p.C124W mutation disrupts this LLPS capability, leading to diminished degradation of RHOB and subsequent excessive accumulation in the postsynaptic density fractions. Notably, neither IDR deletion nor p.C124W mutation in KCTD10 mitigates the synaptic abnormalities caused by Kctd10 deficiency. Thus, our findings implicate that LLPS may be associated with the pathogenesis of KCTD10-associated brain disorders and highlight the potential of targeting RHOB as a therapeutic strategy for diseases linked to mutations in KCTD10 or RHOB.
基金:
National Natural Science Foundation of China (32070980, 32271026, 81901168, 32330038,31921002, and 32394030), the Natural Science Foundation of Hunan Province
(2021JJ20075).
第一作者机构:[1]Center for Medical Genetics, Hunan Key Laboratory of Medical Genetics, Key Lab of Rare Pediatric Diseases of Ministry of Education, School of Life Science, Central South University, Changsha, Hunan 410078, China.
共同第一作者:
通讯作者:
通讯机构:[1]Center for Medical Genetics, Hunan Key Laboratory of Medical Genetics, Key Lab of Rare Pediatric Diseases of Ministry of Education, School of Life Science, Central South University, Changsha, Hunan 410078, China.[6]Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Science, Central South University, Changsha, Hunan 410078, China.
推荐引用方式(GB/T 7714):
Mu Chenjun,Liu Pan,Liu Liang,et al.KCTD10 p.C124W variant contributes to schizophrenia by attenuating LLPS-mediated synapse formation[J].Proceedings Of The National Academy Of Sciences Of The United States Of America.2024,121(48):e2400464121.doi:10.1073/pnas.2400464121.
APA:
Mu Chenjun,Liu Pan,Liu Liang,Wang Yaqing,Liu Kefu...&Yuan Ling.(2024).KCTD10 p.C124W variant contributes to schizophrenia by attenuating LLPS-mediated synapse formation.Proceedings Of The National Academy Of Sciences Of The United States Of America,121,(48)
MLA:
Mu Chenjun,et al."KCTD10 p.C124W variant contributes to schizophrenia by attenuating LLPS-mediated synapse formation".Proceedings Of The National Academy Of Sciences Of The United States Of America 121..48(2024):e2400464121